Pergolide and cabergoline increased risk for valvular heart disease in Parkinson disease
- PMID: 17474685
Pergolide and cabergoline increased risk for valvular heart disease in Parkinson disease
Comment on
-
Valvular heart disease and the use of dopamine agonists for Parkinson's disease.N Engl J Med. 2007 Jan 4;356(1):39-46. doi: 10.1056/NEJMoa054830. N Engl J Med. 2007. PMID: 17202454